Eva Corey

15.1k total citations · 1 hit paper
194 papers, 7.9k citations indexed

About

Eva Corey is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Eva Corey has authored 194 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Pulmonary and Respiratory Medicine, 106 papers in Molecular Biology and 65 papers in Oncology. Recurrent topics in Eva Corey's work include Prostate Cancer Treatment and Research (145 papers), Bone health and treatments (37 papers) and Radiopharmaceutical Chemistry and Applications (28 papers). Eva Corey is often cited by papers focused on Prostate Cancer Treatment and Research (145 papers), Bone health and treatments (37 papers) and Radiopharmaceutical Chemistry and Applications (28 papers). Eva Corey collaborates with scholars based in United States, Canada and South Africa. Eva Corey's co-authors include Robert L. Vessella, Lisha G. Brown, Peter S. Nelson, Colm Morrissey, Lawrence D. True, Ilsa M. Coleman, Holly M. Nguyen, Janna E. Quinn, Theodore D. Koreckij and Celestia S. Higano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Eva Corey

188 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer

2021 215 citations Ali Ghoochani, En‐Chi Hsu et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Corey United States	50	3.9k	3.8k	3.3k	1.8k	1.1k	194	7.9k
David F. Jarrard United States	49	5.0k 1.3×	4.0k 1.1×	2.1k 0.6×	2.0k 1.1×	1.3k 1.2×	207	10.0k
Colm Morrissey United States	48	2.9k 0.8×	3.8k 1.0×	2.2k 0.7×	2.5k 1.4×	451 0.4×	146	7.2k
Ilsa M. Coleman United States	46	4.0k 1.0×	3.8k 1.0×	2.2k 0.7×	2.2k 1.2×	480 0.4×	111	7.8k
William Kevin Kelly United States	46	6.3k 1.6×	5.0k 1.3×	3.9k 1.2×	2.0k 1.1×	1.9k 1.7×	244	11.9k
Roberto Bianco Italy	49	3.4k 0.9×	3.7k 1.0×	5.0k 1.5×	1.2k 0.7×	898 0.8×	208	8.9k
Dominic T. Moore United States	42	2.1k 0.5×	2.7k 0.7×	3.5k 1.1×	2.8k 1.5×	654 0.6×	128	8.0k
Kyoichi Kaira Japan	47	3.4k 0.9×	3.3k 0.9×	4.3k 1.3×	1.5k 0.8×	983 0.9×	425	9.1k
Carmen Behrens United States	57	3.0k 0.8×	5.2k 1.4×	3.9k 1.2×	2.6k 1.4×	512 0.5×	169	9.5k
Ronit Simantov United States	36	4.3k 1.1×	5.5k 1.4×	3.3k 1.0×	2.6k 1.5×	647 0.6×	88	11.2k
Lisa G. Horvath Australia	46	2.5k 0.7×	2.4k 0.6×	2.2k 0.7×	1.6k 0.9×	525 0.5×	198	6.0k

Countries citing papers authored by Eva Corey

Since Specialization

Citations

This map shows the geographic impact of Eva Corey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Corey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Corey more than expected).

Fields of papers citing papers by Eva Corey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Corey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Corey. The network helps show where Eva Corey may publish in the future.

Co-authorship network of co-authors of Eva Corey

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Corey. A scholar is included among the top collaborators of Eva Corey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Corey. Eva Corey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Senatorov, Ilya S., Joel M. Bowman, Keith H. Jansson, et al.. (2024). Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit. Cell Reports Medicine. 5(12). 101868–101868. 2 indexed citations

Sugawara, Tatsuo, Ekaterina Nevedomskaya, Simon Heller, et al.. (2024). Dual targeting of the androgen receptor and PI3K / AKT / mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis. Molecular Oncology. 18(3). 726–742. 13 indexed citations

Ippolito, Joseph E., Jennifer K. Sehn, Cody Weimholt, et al.. (2024). N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype. Molecular Cancer Research. 23(1). 59–70. 2 indexed citations

Bae, Song Yi, J.T. Greene, Eva Corey, et al.. (2023). ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer. Frontiers in Endocrinology. 14. 1093332–1093332. 5 indexed citations

Labrecque, Mark P., Lisha G. Brown, Ilsa M. Coleman, et al.. (2023). Targeting the fibroblast growth factor pathway in molecular subtypes of castration‐resistant prostate cancer. The Prostate. 84(1). 100–110. 4 indexed citations

Coleman, Ilsa M., Navonil De Sarkar, Colm Morrissey, et al.. (2022). Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 28(14). 3127–3140. 18 indexed citations

Krishn, Shiv Ram, Andrew V. Kossenkov, Qin Liu, et al.. (2022). Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells. Cancer Biology & Therapy. 23(1). 173–185. 18 indexed citations

Ghoochani, Ali, En‐Chi Hsu, Merve Aslan, et al.. (2021). Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer. Cancer Research. 81(6). 1583–1594. 215 indexed citations breakdown →

Corella, Alexandra, Ilsa M. Coleman, Jared M. Lucas, et al.. (2019). Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer. Clinical Cancer Research. 26(7). 1667–1677. 32 indexed citations

10.

Mostaghel, Elahe A., Ailin Zhang, Susana Hernández, et al.. (2018). Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer. Clinical Cancer Research. 25(1). 426–439. 49 indexed citations

11.

Beshiri, Michael L., Caitlin M. Tice, Crystal Tran, et al.. (2018). A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening. Clinical Cancer Research. 24(17). 4332–4345. 145 indexed citations

12.

Arai, Seiji, Oliver Jonas, Matthew A. Whitman, et al.. (2018). Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis. Clinical Cancer Research. 24(21). 5458–5470. 50 indexed citations

13.

Suominen, Mari I., Jukka P. Rissanen, Jukka Morko, et al.. (2017). Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models. Clinical Cancer Research. 23(15). 4335–4346. 137 indexed citations

14.

Nyquist, Michael D., Alexandra Corella, Ilsa M. Coleman, et al.. (2017). Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155. Molecular Cancer Research. 15(5). 521–531. 15 indexed citations

15.

Lam, Hung‐Ming, Ryan P. McMullin, Holly M. Nguyen, et al.. (2016). Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts. Clinical Cancer Research. 23(9). 2301–2312. 17 indexed citations

16.

Zhang, Xiaotun, Ilsa M. Coleman, Lisha G. Brown, et al.. (2015). SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 21(20). 4698–4708. 129 indexed citations

17.

Lucas, Jared M., Cynthia Heinlein, Tom Kim, et al.. (2014). The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis. Cancer Discovery. 4(11). 1310–1325. 338 indexed citations

18.

Yin, JuanJuan, Yen‐Nien Liu, Heather Tillman, et al.. (2014). AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis. Cancer Research. 74(16). 4306–4317. 47 indexed citations

19.

Thadani‐Mulero, Maria, Luigi Portella, Shihua Sun, et al.. (2014). Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer. Cancer Research. 74(8). 2270–2282. 191 indexed citations

20.

Zheng, Dali, Keith F. Decker, Tianhua Zhou, et al.. (2013). Role of WNT7B-induced Noncanonical Pathway in Advanced Prostate Cancer. Molecular Cancer Research. 11(5). 482–493. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact